Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Sotera Health (SHC)

Sotera Health Q3 revenue rises 8.5% to $285 million; net income $17 million

Positive Impact 3 of 5 earnings Written later

Sotera Health reported third-quarter 2024 net revenues of $285 million, up 8.5% from a year earlier, and net income of $17 million, or $0.06 per diluted share, compared with a net loss of $14 million a year earlier. The company reaffirmed its 2024 net revenue and Adjusted EBITDA growth outlook, but lowered its capital expenditure forecast to $175 million to $185 million.

Key points

  • Q3 2024 net revenues were $285 million, up 8.5%; Adjusted EBITDA was $146 million, up 9.0%
  • Q3 2024 net income was $17 million ($0.06 per diluted share), versus a net loss of $14 million ($0.05 per share) in Q3 2023
  • 2024 outlook for net revenue and Adjusted EBITDA growth of 4.0% to 6.0% was reaffirmed; Adjusted EPS range of $0.67 to $0.75 was also reaffirmed
  • Capital expenditure guidance was updated to $175 million to $185 million, from $205 million to $225 million previously

The filing

CompanySotera Health (SHC)
Form8-K, current report
Filed with the SECNov 5, 2024, 7:08 AM ET
Accession number0001822479-24-000046

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.